The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HSD3B1 genotype and abiraterone (Abi) metabolites in patients (pts) with prostate cancer (PCa).
 
Hamid Emamekhoo
No Relationships to Disclose
 
Mohammad Alyamani
No Relationships to Disclose
 
Sunho Park
No Relationships to Disclose
 
Jennifer Taylor
No Relationships to Disclose
 
Nima Almassi
No Relationships to Disclose
 
Sunil Upadhyay
No Relationships to Disclose
 
Allison Janine Tyler
Honoraria - AstraZeneca; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - AstraZeneca; Bayer
 
Mike Berk
No Relationships to Disclose
 
Tae Hyun Hwang
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; EMD Serono; Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Richard J. Auchus
Honoraria - Quest Diagnostics
Consulting or Advisory Role - Alder Biopharmaceuticals; Corcept Therapeutics; Diurnal; Janssen; Novartis; Spruce Biosciences; Strongbridge Bio
Research Funding - Millendo; Novartis; Strongbridge Bio
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Corcept Therapeutics; Novartis; Strongbridge Bio
 
Nima Sharifi
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Sanofi
Research Funding - Druggablity Technologies; Janssen Oncology
Patents, Royalties, Other Intellectual Property - A patent application has been filed by Cleveland Clinic for a method of steroid-dependent disease treatment based on HSD3B1. Nima Sharifi is a co-inventor on this patent application